Lucas Salas, MD, MPH, PhD
Lucas Salas, MD, MPH, PhD – Department of Epidemiology
Universitat Pompeu Fabra, PhD 2015
Universitat Pompeu Fabra, MPH 2011
Universidad de Antioquia, Epidemiology 2007
Universidad Nacional de Colombia, MD 2001
Phone: (603) 646-5496
Email: Lucas.A.Salas@dartmouth.edu
Dr. Salas is a physician-scientist and molecular epidemiologist whose research bridges genomics, cancer biology, and environmental health. At Dartmouth’s Geisel School of Medicine, he leads a translational research program focused on understanding how cellular heterogeneity influences human health and disease, particularly in urogenital cancers such as renal and ovarian cancer. His lab integrates epigenomic profiling, single-cell technologies, and computational modeling to study immune mechanisms, gene regulation, and biomarker discovery.
Dr. Salas is the developer of widely used epigenetic deconvolution tools—including FlowSorted.Blood.EPIC and FlowSorted.CordBloodCombined.450k on Bioconductor—and has led the development of advanced tumor profiling platforms like HiTIMED, GIMiCC, and HiTAIC, which aid in immune microenvironment mapping and tumor origin classification. His work has been featured in Nature Communications and Genome Biology, and has informed both translational science and public health policy.
A native of Colombia, Dr. Salas received his MD from Universidad Nacional de Colombia, a Master’s in Epidemiology from Universidad de Antioquia, and both his MPH and PhD from Universitat Pompeu Fabra/ISGlobal in Barcelona. He completed postdoctoral training at Dartmouth in molecular epidemiology and has since become a national advocate for kidney cancer research, serving on multiple NIH- and DoD-funded projects.